Why Did Salarius (SLRX) Shares Soar Over 23% After-Hours?

fidelity
2025.11.12 03:31
portai
I'm PortAI, I can summarize articles.

Salarius Pharmaceuticals Inc. (SLRX) shares rose 23.65% in after-hours trading to $1.21 following the announcement of a $7 million underwritten public offering. The offering includes 2.51 million common shares and pre-funded warrants for 2.15 million shares at $1.50 each. The completion of the offering is contingent on a merger with Decoy Therapeutics Inc. Despite the after-hours surge, SLRX stock is down 96.25% year-to-date, with a market cap of $1.03 million.

Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.